Spatial and temporal homogeneity of driver mutations in diffuse intrinsic pontine glioma

Nature Communications

Volumn 7, Issue , 2016, Pages

  Nikbakht, Hamid ^a   Panditharatna, Eshini ^b,c   Mikael, Leonie G ^d   Li, Rui ^a   Gayden, Tenzin ^a   Osmond, Matthew ^a   Ho, Cheng Ying ^e   Kambhampati, Madhuri ^b   Hwang, Eugene I ^e   Faury, Damien ^d   Siu, Alan ^c   Papillon Cavanagh, Simon ^a   Bechet, Denise ^a   Ligon, Keith L ^f   Ellezam, Benjamin ^g   Ingram, Wendy J ^h   Stinson, Caedyn ^h   Moore, Andrew S ^h,i   Warren, Katherine E ^j   Karamchandani, Jason ^k   Packer, Roger J ^e   Jabado, Nada ^a,d   Majewski, Jacek ^a   Nazarian, Javad ^a,c   more..

^a MCGILL UNIVERSITY   (Canada)

^b CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^c GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^d RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^e CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^f DANA FARBER CANCER INSTITUTE   (United States)

^g UNIVERSITY OF MONTREAL   (Canada)

^h UNIVERSITY OF QUEENSLAND   (Australia)

ⁱ LADY CILENTO CHILDREN S HOSPITAL   (Australia)

^j NATIONAL CANCER INSTITUTE   (United States)

^k MCGILL UNIVERSITY   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN RECEPTOR LIKE KINASE 1; DNA; GROWTH FACTOR; HISTONE H3; PHOSPHATIDYLINOSITOL 3 KINASE; PIK3R1 PROTEIN; PROTEIN P53; RNA; UNCLASSIFIED DRUG; ACTIVIN RECEPTOR 1; ACVR1 PROTEIN, HUMAN; HISTONE; PHOSPHOPROTEIN PHOSPHATASE; PIK3R1 PROTEIN, HUMAN; PPM1D PROTEIN, HUMAN; PROTEIN PHOSPHATASE 2C; TP53 PROTEIN, HUMAN;

BRAIN; GROWTH RATE; HETEROGENEITY; HOMOGENEITY; MUTATION; RECONSTRUCTION; TUMOR;

ARTICLE; AUTOPSY; BRAIN BIOPSY; BRAIN METASTASIS; BRAIN TISSUE; CARCINOGENESIS; CELL CYCLE; CLONAL EVOLUTION; COPY NUMBER VARIATION; DNA METHYLATION; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; HISTONE UBIQUITINATION; HUMAN; HUMAN TISSUE; NEEDLE BIOPSY; NEUROANATOMY; NEUROPATHOLOGY; PONTINE GLIOMA; SIGNAL TRANSDUCTION; TUMOR BIOPSY; BRAIN; BRAIN MAPPING; BRAIN STEM; BRAIN STEM TUMOR; CHILD; GENE EXPRESSION REGULATION; GENETICS; GLIOMA; METABOLISM; MUTATION; PATHOLOGY; STEREOTACTIC PROCEDURE; TIME FACTOR;

ACTIVIN RECEPTORS, TYPE I; AUTOPSY; BRAIN MAPPING; BRAIN STEM; BRAIN STEM NEOPLASMS; CARCINOGENESIS; CEREBRUM; CHILD; CLONAL EVOLUTION; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; HISTONES; HUMANS; MUTATION; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHOPROTEIN PHOSPHATASES; PROTEIN PHOSPHATASE 2C; SIGNAL TRANSDUCTION; STEREOTAXIC TECHNIQUES; TIME FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84963665507     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms11185     Document Type: Article

References (39)

1. Buczkowicz, P., Bartels, U., Bouffet, E., Becher, O. and Hawkins, C. Histopathological spectrum of paediatric diffuse intrinsic pontine glioma: diagnostic and therapeutic implications. Acta. Neuropathol. 128, 573-581 (2014).
2. Khuong-Quang, D. A. et al. K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas. Acta. Neuropathol. 124, 439-447 (2012).
3. Schwartzentruber, J. et al. Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature 482, 226-231 (2012).
4. Wu, G. et al. Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas. Nat. Genet. 44, 251-253 (2012).
5. Buczkowicz, P. et al. Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations. Nat. Genet. 46, 451-456 (2014).
6. Fontebasso, A. M. et al. Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma. Nat. Genet. 46, 462-466 (2014).
7. Taylor, K. R. et al. Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma. Nat. Genet. 46, 457-461 (2014).
8. Wu, G. et al. The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma. Nat. Genet. 46, 444-450 (2014).
9. Kumar, A. et al. Deep sequencing of multiple regions of glial tumors reveals spatial heterogeneity for mutations in clinically relevant genes. Genome Biol. 15, 530 (2014).
10. Sottoriva, A. et al. Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics. Proc. Natl Acad. Sci. USA 110, 4009-4014 (2013).
11. Szerlip, N. J. et al. Intratumoral heterogeneity of receptor tyrosine kinases EGFR and PDGFRA amplification in glioblastoma defines subpopulations with distinct growth factor response. Proc. Natl Acad. Sci. USA 109, 3041-3046 (2012).
12. Bechet, D. et al. Specific detection of methionine 27 mutation in histone 3 variants (H3K27M) in fixed tissue from high-grade astrocytomas. Acta Neuropathol. 128, 733-741 (2014).
13. Caretti, V. et al. Subventricular spread of diffuse intrinsic pontine glioma. Acta Neuropathol. 128, 605-607 (2014).
14. Gerlinger, M. et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N. Engl. J. Med. 366, 883-892 (2012).
15. Eleveld, T. F. et al. Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations. Nat. Genet. 47, 864-871 (2015).
16. Wu, X. et al. Clonal selection drives genetic divergence of metastatic medulloblastoma. Nature 482, 529-533 (2012).
17. Johnson, B. E. et al. Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma. Science 343, 189-193 (2014).
18. Walker, D. A. et al. A multi-disciplinary consensus statement concerning surgical approaches to low-grade, high-grade astrocytomas and diffuse intrinsic pontine gliomas in childhood (CPN Paris 2011) using the Delphi method. Neuro. Oncol. 15, 462-468 (2013).
19. Kambhampati, M. et al. A standardized autopsy procurement allows for the comprehensive study of DIPG biology. Oncotarget 6, 12740-12747 (2015).
20. Castel, D. et al. Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes. Acta Neuropathol. 130, 815-827 (2015).
21. Nik-Zainal, S. et al. Mutational processes molding the genomes of 21 breast cancers. Cell 149, 979-993 (2012).
22. Popic, V. et al. Fast and scalable inference of multi-sample cancer lineages. Genome. Biol. 16, 91 (2015).
23. Zhang, L. et al. Exome sequencing identifies somatic gain-of-function PPM1D mutations in brainstem gliomas. Nat. Genet. 46, 726-730 (2014).
24. Koren, S. et al. PIK3CA(H1047R) induces multipotency and multi-lineage mammary tumours. Nature 525, 114-118 (2015).
25. Karar, J. and Maity, A. PI3K/AKT/mTOR Pathway in Angiogenesis. Front. Mol. Neurosci. 4, 51 (2011).
26. Lewis, P. W. et al. Inhibition of PRC2 activity by a gain-of-function H3 mutation found in pediatric glioblastoma. Science 340, 857-861 (2013).
27. Funato, K., Major, T., Lewis, P. W., Allis, C. D. and Tabar, V. Use of human embryonic stem cells to model pediatric gliomas with H3.3K27M histone mutation. Science 346, 1529-1533 (2014).
28. Hindson, C. M. et al. Absolute quantification by droplet digital PCR versus analog real-time PCR. Nat. Methods 10, 1003-1005 (2013).
29. McKenna, A. et al. The genome analysis toolkit: a mapreduce framework for analyzing next-generation DNA sequencing data. Genome Res. 20, 1297-1303 (2010).
30. Li, H. and Durbin, R. Fast and accurate short read alignment with burrows-wheeler transform. Bioinformatics 25, 1754-1760 (2009).
31. Li, H. et al. The sequence alignment/map format and SAMtools. Bioinformatics 25, 2078-2079 (2009).
32. Wang, K., Li, M. and Hakonarson, H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 38, e164 (2010).
33. Shi, Y. and Majewski, J. FishingCNV: a graphical software package for detecting rare copy number variations in exome-sequencing data. Bioinformatics 29, 1461-1462 (2013).
34. Nadaf, J., Majewski, J. and Fahiminiya, S. ExomeAI: detection of recurrent allelic imbalance in tumors using whole-exome sequencing data. Bioinformatics 31, 429-431 (2015).
35. Deshwar, A. G. et al. PhyloWGS: reconstructing subclonal composition and evolution from whole-genome sequencing of tumors. Genome Biol. 16, 35 (2015).
36. Love, M. I., Huber, W. and Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome. Biol. 15, 550 (2014).
37. Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15-21 (2013).
38. Carbon, S. et al. AmiGO: online access to ontology and annotation data. Bioinformatics 25, 288-289 (2009).
39. Huang, da, W., Sherman, B. T. and Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44-57 (2009).